Director McCoy bought 70,000 RPC shares at $7.37; holdings up 35.0% to 270.1K shares
McCoy David M., a Director of Ridgepost Capital, purchased 70,000 shares at $7.37 on 2026-03-23, increasing his holdings by 35.0% from 200.1K to 270.1K shares. The current price of $7.03 sits 33.6% below the 52-week high of $10.58, and the stock has declined 12.6% over the last 30 days. Across his cross-ticker track record, McCoy's 5 prior buys averaged +6.7% returns over 30 days with a 40% win rate, suggesting mixed timing accuracy on purchases. The company's fundamentals show modest revenue of $75.9M with minimal annual growth of +0.3%, and a notably elevated P/E ratio of 39.06 relative to net income of $2.1M, warranting deeper examination of valuation and profitability drivers.
Director McCoy David M. sold 90,000 shares of PX at $12.16 for $1.1M, reducing stake to 214.3K shares (-29.6%).
Director McCoy David M. liquidated a significant portion of his PX holdings, selling 90,000 shares (29.6% of his pre-transaction position) at $12.16 on 2025-03-25 for $1,094,400.00. The sale occurred when the stock was trading 16.4% below its 52-week high of $14.17, and subsequent price action shows the stock has declined 6.2% over the past 30 days and 6.0% over 90 days. His same-ticker history at PX shows mixed timing outcomes: of 5 prior buy trades, only 2 achieved positive 90-day returns, indicating he has struggled to time entries at this ticker with consistency. The current P/E ratio of 69.71 combined with modest profitability ($1.4M net income on $74.2M revenue) suggests elevated valuation relative to earnings, though annual revenue growth of 22.6% indicates operational momentum.
David M. McCoy buys 20,000 shares of PX at $8.21; stock down 34.6% from 52-week high despite 21.9% revenue growth.
McCoy purchased 20,000 shares at $8.21 on 2024-06-21, increasing his holdings by 25.1% to 99.5K shares. The stock currently trades at $8.25, well below its 52-week high of $12.62 (down 34.6%), and McCoy's cross-ticker track record shows a 25% success rate on 90-day buy timing. At PX specifically, his prior four buys produced only 1 positive 90-day return, suggesting mixed execution timing at this ticker. The company reported $66.1M in latest quarterly revenue (up 21.9% annually) but was unprofitable over its most recent full fiscal year, creating a mixed fundamental backdrop where strong top-line growth coexists with near-term losses. This buy occurred against a backdrop of depressed valuation relative to the 52-week range, but absent scheduled trading plan disclosures, the lack of a clear timing advantage in his same-ticker history and the company's current net loss warrant closer monitoring of whether this signals informed conviction or standard portfolio maintenance.
